SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-055368
Filing Date
2023-07-07
Accepted
2023-07-07 11:11:01
Documents
15
Period of Report
2023-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea181425-8k_lucyscien.htm   iXBRL 8-K 29559
2 FIRST AMENDMENT TO THE ASSET PURCHASE AGREEMENT DATED JUNE 30, 2023 AMONG LUCY S ea181425ex10-1_lucyscien.htm EX-10.1 28762
3 PRESS RELEASE OF LUCY SCIENTIFIC DISCOVERY INC. DATED JULY 5, 2023 ea181425ex99-1_lucyscien.htm EX-99.1 12682
4 GRAPHIC ex99-1_001.jpg GRAPHIC 2329
  Complete submission text file 0001213900-23-055368.txt   259990

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lsdi-20230630.xsd EX-101.SCH 2977
6 XBRL LABEL FILE lsdi-20230630_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE lsdi-20230630_pre.xml EX-101.PRE 22371
9 EXTRACTED XBRL INSTANCE DOCUMENT ea181425-8k_lucyscien_htm.xml XML 3616
Mailing Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6
Business Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6 778-410-5195
Lucy Scientific Discovery, Inc. (Filer) CIK: 0001865127 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41616 | Film No.: 231075699
SIC: 2834 Pharmaceutical Preparations